HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E. (Q45019739)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX(®) B/E. (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

0 references

1 reference

based on heuristic

inferred from title

14

object named as

Jerome H Kim

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Victoria R Polonis

12

object named as

Victoria R Polonis

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

author name string

Robert Paris

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sasitorn Bejrachandra

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Prasert Thongcharoen

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sorachai Nitayaphan

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Punnee Pitisuttithum

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Anna Sambor

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sanjay Gurunathan

7

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Donald Francis

8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Silvia Ratto-Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Chitraporn Karnasuta

10

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Mark S de Souza

11

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Arthur E Brown

13

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Henry A Stephens

15

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Thai AIDS Vaccine Evaluation Group

16

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

language of work or name

0 references

publication date

12 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

832-836

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

The challenge of HIV-1 subtype diversity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

HIV-1 diversity versus HLA class I polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

HLA class I serotypes and cytotoxic T-lymphocyte responses among human immunodeficiency virus-1-uninfected Thai volunteers immunized with ALVAC-HIV in combination with monomeric gp120 or oligomeric gp160 protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

The immune system. Second of two parts

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

Peptide binding predictions for HLA DR, DP and DQ molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

HLA-A, -B, -DRB1, -DQA1, and -DQB1 polymorphism in Thais

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

A comparison of molecular HLA-DR and DQ allele profiles forming DR51-, DR52-, and DR53-related haplotypes in five ethnic Thai populations from mainland southeast Asia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

The presence of the HLA class II allele DPB1*0501 in ethnic Thais correlates with an enhanced vaccine-induced antibody response to a malaria sporozoite antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

Specific Antibody Responses to Vaccination with Bivalent CM235/SF2 gp120: Detection of Homologous and Heterologous Neutralizing Antibody to Subtype E (CRF01.AE) HIV Type 1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

The immune response to hepatitis B vaccine in humans: inheritance patterns in families

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

Molecular mechanisms of HLA association with autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

Naturally processed peptides from HLA-DQ7 (alpha1*0501-beta1*0301): influence of both alpha and beta chain polymorphism in the HLA-DQ peptide binding specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

MHC class II epitope predictive algorithms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.11.002

7 January 2021

Identifiers

10.1016/J.VACCINE.2011.11.002

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45019739&oldid=1369016952"